ADVENTRX Pharmaceuticals Cash and ST Investments: 38.29M
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
None selected
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
ANX Cash and ST Investments Rankings
| Overall | 35th percentile | 2941 of 4527 |
| Sector | 40th percentile | 310 of 519 in Healthcare |
| Industry | 36th percentile | 103 of 163 in Biotechnology |
ANX Cash and ST Investments Range, Past 5 Years
| Minimum | 0.06M | Jun 2002 |
| Maximum | 51.75M | Dec 2006 |
| Average | 12.34M |
About Cash and Short Term Investments
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities
Learn More
You may also be interested in these ANX related companies
ANX News
ADVENTRX Pharmaceuticals to Present at the 14th Annual BIO CEO & Investor Conference on February 14
Feb 07, 8:00AM PR Newswire
Feb 07, 8:00AM PR Newswire
Call me paranoid, but I have a lot of problems with tickers that have an X in them, $ANX $ALXA $BPAX... All equate to "ex money" LOL
about 8 days ago by GaryJPalys
about 8 days ago by GaryJPalys
@StockCowboy $ANX I agree, still holding here too. Thanks, enjoy your weekend as well!
about 9 days ago by Random_Walk
about 9 days ago by Random_Walk
$ANX http://stks.co/2Ey2 Ready to bounce off new support level @ $.66
about 9 days ago by StockCowboy
about 9 days ago by StockCowboy
$ANX http://stks.co/2EAG Nice 50DMA dead cat bounce breakout. Bullish volume. Expect the rally to stall at resistance levels
about 9 days ago by Ensui67
about 9 days ago by Ensui67
RT @Urbane_Gorilla $ANX has 1.45 per share cash and trades at 0.72?
about 11 days ago by StockCowboy
about 11 days ago by StockCowboy
Biotech Sector on the Upswing -- Dendreon and ADVENTRX Pharmaceuticals Looking Strong
Jan 31, 8:20AM Marketwire
Jan 31, 8:20AM Marketwire
RT @GarethSoloway Gave $ANX a few days ago, trading 1/2 cash. Rocking today. Congrats to those that took it and held.
about 16 days ago by InTheMoneyStocks
about 16 days ago by InTheMoneyStocks
Gave $ANX a few days ago, trading 1/2 cash. Rocking today. Congrats to those that took it and held.
about 16 days ago by GarethSoloway
about 16 days ago by GarethSoloway
Vista Partners Updates Coverage on ADVENTRX Pharmaceuticals, Inc.; $3.50 Target Price
Dec 15, 9:21AM Benzinga
Dec 15, 9:21AM Benzinga
ADVENTRX (ANX) Discusses ANX-188 Phase 3 Structure w/ FDA; Additional Info Needed for Finalization
Dec 01, 8:40AM Street Insider
Dec 01, 8:40AM Street Insider
Speculative Healthcare Companies IntelGenx and Adventrx Begin to Gain Ground
Nov 15, 8:16AM Marketwire
Nov 15, 8:16AM Marketwire
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| ANX | 0.71 | -0.01 | -0.78% | 18.93M |
| ESC | 18.43 | -0.47 | -2.49% | 816.45M |
| GCI | 14.61 | -0.42 | -2.79% | 3.48B |
| JNJ | 64.60 | -0.29 | -0.45% | 176.41B |
| APD | 90.40 | -0.65 | -0.71% | 19.03B |
| NDN | 22.01 | 0.02 | 0.09% | 1.55B |
| NRG | 17.32 | 0.24 | 1.41% | 4.18B |
| CNL | 39.24 | -0.26 | -0.66% | 2.40B |
| BIG | 44.00 | 0.16 | 0.36% | 2.88B |
| NWK | 0.92 | -0.04 | -4.17% | 28.01M |
